发明授权
US09084770B2 Modulation of insulin like growth factor I receptor expression in cancer
有权
调节胰岛素样生长因子I受体在癌症中的表达
- 专利标题： Modulation of insulin like growth factor I receptor expression in cancer
- 专利标题（中）： 调节胰岛素样生长因子I受体在癌症中的表达
-
申请号： US12578471申请日： 2009-10-13
-
公开(公告)号： US09084770B2公开(公告)日： 2015-07-21
- 发明人: George Tachas , Lynne Maree Atley , Christopher J. Wraight
- 申请人： George Tachas , Lynne Maree Atley , Christopher J. Wraight
- 申请人地址： AU Toorak
- 专利权人： Antisense Therapeutics, Ltd.
- 当前专利权人： Antisense Therapeutics, Ltd.
- 当前专利权人地址： AU Toorak
- 代理机构： Bozicevic, Field & Francis LLP
- 代理商 Carol L. Francis
- 主分类号： C12N15/113
- IPC分类号： C12N15/113 ; A61K31/337 ; A61K31/7052
摘要：
Provided herein are methods, compounds, and compositions for reducing expression of an IGF-IR mRNA and protein in an animal. Also provided herein are methods, compounds, and compositions that inhibit expression of IGF-IR in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate the tumor or cancer, or a symptom thereof.
公开/授权文献
信息查询
IPC分类:
